CASE REPORT
Published on 14 Aug 2025
Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature
doi 10.3389/fimmu.2025.1616361
- 292 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
8,240
Total downloads
39k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 30 Jul 2025
Comprehensive analysis of regulatory B Cell related genes in prognosis and therapeutic response in lung adenocarcinoma
doi 10.3389/fimmu.2025.1595408
- 1,199 views
ORIGINAL RESEARCH
Published on 09 Jul 2025
CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis
doi 10.3389/fimmu.2025.1589423
- 1,127 views
ORIGINAL RESEARCH
Published on 30 May 2025
GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma
doi 10.3389/fimmu.2025.1572757
- 2,111 views
ORIGINAL RESEARCH
Published on 30 May 2025
Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment
doi 10.3389/fimmu.2025.1553882
- 1,435 views
SYSTEMATIC REVIEW
Published on 26 May 2025
Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1592761
- 1,317 views
SYSTEMATIC REVIEW
Published on 16 May 2025
Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fonc.2025.1532343
- 1,288 views
REVIEW
Published on 08 May 2025
Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer
doi 10.3389/fimmu.2025.1554871
- 2,842 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 May 2025
Toll-like receptor 3 activation enhances antitumor immune response in lung adenocarcinoma through NF-κB signaling pathway
doi 10.3389/fimmu.2025.1585747
- 1,270 views
- 1 citation
ORIGINAL RESEARCH
Published on 17 Apr 2025
BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer
doi 10.3389/fimmu.2025.1562700
- 1,972 views
ORIGINAL RESEARCH
Published on 04 Apr 2025
Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia
doi 10.3389/fimmu.2025.1513040
- 1,946 views
REVIEW
Published on 24 Feb 2025
IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications
doi 10.3389/fimmu.2025.1515718
- 2,242 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: